IceCure Medical (ICCM) appointed Meir Peleg as its CFO, effective May 17. Meir Peleg combines a software engineering background with over 20 years of financial leadership, having previously served as a strategic partner to CEOs and boards. In addition, IceCure plans to appoint Richard Fine in Q2 as the company’s Medical Director to lead breast indications. Fine is a breast surgical oncologist and Director of the Breast Program at the Margaret West Comprehensive Breast Center at West Cancer Center & Research Institute in Germantown, Tennessee. The company has initiated a search for a new Chief Technology Officer. Naum Muchnik, IceCure’s VP of R&D and Engineering, will be departing his role effective April 12.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICCM:
- Buy Rating Reaffirmed on ProSense Momentum, Global Expansion, and Undervalued Breast Cancer Cryoablation Opportunity
- Icecure Medical Rides FDA, ASBRS Wins to Growth
- IceCure Medical Discloses Resignation of Director Li Haixiang
- IceCure Medical Posts Record 2025 Sales as ProSense Cryoablation Adoption Accelerates Post-FDA Clearance
- IceCure Medical reports FY25 EPS 24c vs 30c last year
